Article

expressandstar.comexpressandstar.com on 2023-05-03 14:22

World ‘on cusp of first generation of treatments for Alzheimer’s’

Almost half of those on donanemab had no clinical progression of disease at one year compared to 29% on placebo, a study showed.

Related news